Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arash Arashkia

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Nature Biotechnology|July 14, 2021
Ebola as a case study for the patent landscape of medical countermeasures for emerging infectious diseasesNasir Mohajel, Arash Arashkia
Cancer Cell International|November 24, 2022
Modifying oncolytic virotherapy to overcome the barrier of the hypoxic tumor microenvironment. Where do we stand?Sara Shayan, Arash Arashkia, Kayhan Azadmanesh
Protein and Peptide Letters|January 17, 2018
Generation of the Fluorescent HPV16 E7 Protein for Detection of Delivery In vitroSepideh Shahbazi, Azam Bolhassani, Arash Arashkia, et al.
Iranian Biomedical Journal|January 10, 2023
In silico Identification of Hypoxic Signature followed by reverse transcription-quantitative PCR Validation in Cancer Cell LinesSara Shayan, Golnaz Bahramali, Arash Arashkia, et al.
Avicenna Journal of Medical Biotechnology|April 15, 2024
Investigating the Effects of <i>HMGB1</i> Overexpression on Colorectal Cancer Cell Migration <i>via</i> Oncolytic <i>Herpes simplex</i> Virus Type 1 (oHSV-1)Sara Shayan, Arash Arashkia, Golnaz Bahramali, et al.
Iranian Biomedical Journal|November 18, 2023
Nona-Arginine Mediated Anti-E6 ShRNA Delivery Suppresses the Growth of Hela Cells in vitroRazieh Taghizadeh Pirposhteh, Ehsan Arefian, Arash Arashkia, et al.
Microbial Pathogenesis|August 6, 2019
Generation of recombinant measles virus containing the wild-type P gene to improve its oncolytic efficiencyRoghayeh Alizadeh, Mostafa Ghanei, Arash Arashkia, et al.
Iranian Biomedical Journal|August 28, 2019
Contribution of Streptokinase-Domains from Groups G and A (SK2a) Streptococci in Amidolytic/Proteolytic Activities and Fibrin-Dependent Plasminogen activation: A Domain-Exchange StudyMaryam Rafipour, Malihe Keramati, Mohammad Mehdi Aslani, et al.
Journal of Medical Virology|November 28, 2019
VP7 and VP4 genotypes of rotaviruses cocirculating in Iran, 2015 to 2017: Comparison with cogent sequences of Rotarix and RotaTeq vaccine strains before their use for universal mass vaccinationMahdieh Motamedi-Rad, Mohammad Farahmand, Arash Arashkia, et al.
Pharmacology & Therapeutics|June 2, 2020
Strategies for enhancing intratumoral spread of oncolytic adenovirusesNasser Hashemi Goradel, Babak Negahdari, Sajjad Ghorghanlu, et al.
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Nature Biotechnology|July 14, 2021
Ebola as a case study for the patent landscape of medical countermeasures for emerging infectious diseasesNasir Mohajel, Arash Arashkia
Cancer Cell International|November 24, 2022
Modifying oncolytic virotherapy to overcome the barrier of the hypoxic tumor microenvironment. Where do we stand?Sara Shayan, Arash Arashkia, Kayhan Azadmanesh
Protein and Peptide Letters|January 17, 2018
Generation of the Fluorescent HPV16 E7 Protein for Detection of Delivery In vitroSepideh Shahbazi, Azam Bolhassani, Arash Arashkia, et al.
Iranian Biomedical Journal|January 10, 2023
In silico Identification of Hypoxic Signature followed by reverse transcription-quantitative PCR Validation in Cancer Cell LinesSara Shayan, Golnaz Bahramali, Arash Arashkia, et al.
Avicenna Journal of Medical Biotechnology|April 15, 2024
Investigating the Effects of <i>HMGB1</i> Overexpression on Colorectal Cancer Cell Migration <i>via</i> Oncolytic <i>Herpes simplex</i> Virus Type 1 (oHSV-1)Sara Shayan, Arash Arashkia, Golnaz Bahramali, et al.
Iranian Biomedical Journal|November 18, 2023
Nona-Arginine Mediated Anti-E6 ShRNA Delivery Suppresses the Growth of Hela Cells in vitroRazieh Taghizadeh Pirposhteh, Ehsan Arefian, Arash Arashkia, et al.
Microbial Pathogenesis|August 6, 2019
Generation of recombinant measles virus containing the wild-type P gene to improve its oncolytic efficiencyRoghayeh Alizadeh, Mostafa Ghanei, Arash Arashkia, et al.
Iranian Biomedical Journal|August 28, 2019
Contribution of Streptokinase-Domains from Groups G and A (SK2a) Streptococci in Amidolytic/Proteolytic Activities and Fibrin-Dependent Plasminogen activation: A Domain-Exchange StudyMaryam Rafipour, Malihe Keramati, Mohammad Mehdi Aslani, et al.
Journal of Medical Virology|November 28, 2019
VP7 and VP4 genotypes of rotaviruses cocirculating in Iran, 2015 to 2017: Comparison with cogent sequences of Rotarix and RotaTeq vaccine strains before their use for universal mass vaccinationMahdieh Motamedi-Rad, Mohammad Farahmand, Arash Arashkia, et al.
Pharmacology & Therapeutics|June 2, 2020
Strategies for enhancing intratumoral spread of oncolytic adenovirusesNasser Hashemi Goradel, Babak Negahdari, Sajjad Ghorghanlu, et al.
Pageof 9